{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:38Z","timestamp":1794330338740,"version":"4.9.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12876-017-0668-8","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T06:48:14Z","timestamp":1508914094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1189-4287","authenticated-orcid":false,"given":"Shunichiro","family":"Fujiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Akuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,25]]},"reference":[{"key":"668_CR1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749\u201361.","journal-title":"Lancet"},{"key":"668_CR2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838\u201351.","journal-title":"Lancet"},{"key":"668_CR3","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","volume":"9","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost. 2011;9:1713\u201323.","journal-title":"J Thromb Haemost"},{"key":"668_CR4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217\u201331.","journal-title":"J Hepatol"},{"key":"668_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797\u2013805.","journal-title":"Hepatology"},{"key":"668_CR6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrgastro.2014.36","volume":"11","author":"X Qi","year":"2014","unstructured":"Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nature Rev Gastroenterol Hepatol. 2014;11:435\u201346.","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"668_CR7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","volume":"51","author":"MA Zocco","year":"2009","unstructured":"Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol. 2009;51:682\u20139.","journal-title":"J Hepatol"},{"key":"668_CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0168-8278(05)80660-9","volume":"16","author":"G Zironi","year":"1992","unstructured":"Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 1992;16:298\u2013303.","journal-title":"J Hepatol"},{"key":"668_CR9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD De Leve","year":"2009","unstructured":"De Leve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729\u201364.","journal-title":"Hepatology"},{"key":"668_CR10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1538-7836.2006.01887.x","volume":"4","author":"JC Reverter","year":"2006","unstructured":"Reverter JC. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes. J Thromb Haemost. 2006;4:717\u201320.","journal-title":"J Thromb Haemost"},{"key":"668_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2010.01.005","volume":"21","author":"S Basili","year":"2010","unstructured":"Basili S, Raparelli V, Violi F. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Eur J Intern Med. 2010;21:62\u20134.","journal-title":"Eur J Intern Med"},{"key":"668_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMra0901512","volume":"362","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823\u201332.","journal-title":"N Engl J Med"},{"key":"668_CR13","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2009.08.045","volume":"137","author":"A Tripodi","year":"2009","unstructured":"Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009;137:2105\u201311.","journal-title":"Gastroenterology"},{"key":"668_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejim.2010.02.001","volume":"21","author":"A Tripodi","year":"2010","unstructured":"Tripodi A. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No. Eur J Intern Med. 2010;21:65\u20139.","journal-title":"Eur J Intern Med"},{"key":"668_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","volume":"365","author":"A Tripodi","year":"2011","unstructured":"Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147\u201356.","journal-title":"N Engl J Med"},{"key":"668_CR16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1538-7836.2006.01886.x","volume":"4","author":"PM Mannucci","year":"2006","unstructured":"Mannucci PM. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. J Thromb Haemost. 2006;4:721\u20133.","journal-title":"J Thromb Haemost"},{"key":"668_CR17","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1538-7836.2006.02103.x","volume":"4","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Saito H. Abnormal hemostasis tests and bleeding in chronic liver disease:are they related? No, but they need a careful look. J Thromb Haemost. 2006;4:2066\u20137.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"668_CR18","first-page":"58","volume":"22","author":"DG Meuleman","year":"1992","unstructured":"Meuleman DG. Orgaran (org 10172): its pharmacological profile in experimental models. Haemostasis. 1992;22(2):58\u201365.","journal-title":"Haemostasis"},{"key":"668_CR19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0049-3848(82)90082-2","volume":"27","author":"DG Meuleman","year":"1982","unstructured":"Meuleman DG, Hobbelen PM, Van Dedem G, et al. A novel anti-thrombotic heparonoid (org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models. Thromb Res. 1982;27:353\u201363.","journal-title":"Thromb Res"},{"key":"668_CR20","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.12400","volume":"45","author":"N Naeshiro","year":"2015","unstructured":"Naeshiro N. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015;45:656\u201362.","journal-title":"Hepatol Res"},{"key":"668_CR21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/1319-3767.141680","volume":"20","author":"X Qi","year":"2014","unstructured":"Qi X, Yang Z, Fan D. Spontaneous resolution of portal vein thrombosis in liver cirrhosis: where do we stand, and where will we do? Saudi J Gastroenterol. 2014;20:265\u20136.","journal-title":"Saudi J Gastroenterol"},{"key":"668_CR22","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1148\/radiol.12122259","volume":"266","author":"X Qi","year":"2013","unstructured":"Qi X, Wang J, Chen H, Han G, Fan D. Nonmalignant partial portal vein thrombosis in liver cirrhosis: to treat or not to treat? Radiology. 2013;266:994\u20135.","journal-title":"Radiology"},{"key":"668_CR23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","volume":"54","author":"C Francoz","year":"2005","unstructured":"Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691\u20137.","journal-title":"Gut"},{"key":"668_CR24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/SLA.0b013e3181bdf8ad","volume":"251","author":"H Kawanaka","year":"2010","unstructured":"Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N, Tomikawa M, Maehara Y. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010;251:76\u201383.","journal-title":"Ann Surg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-017-0668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T06:48:25Z","timestamp":1508914105000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-017-0668-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,25]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1186\/s12876-017-0668-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,25]]},"article-number":"112"}}